miscsubjectsAI governance
Evidence review

NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers

bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `nad-plus-stimulants`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/nad-plus-stimulants

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/nad-plus-stimulants/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/nad-plus-stimulants/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/nad-plus-stimulants/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/nad-plus-stimulants/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down if you have Stimulant load (Adderall / amphetamine)

  1. Amphetamines force dopamine and norepinephrine release — borrow focus now.
  2. Sleep, appetite, and gut lining often suffer — less regeneration window.
  3. Chronic load can deplete neurochemistry and stress the gut-brain axis.

Layers:

  • Dopamine system: Forced release → depletion → crash, anhedonia, tolerance.
  • Sleep: Stimulants delay sleep onset and cut deep sleep.
  • Gut: Stimulants stress mucosa; gut inflammation affects mood and cognition.
  • Anxiety: Arousal without calm → jitter, rumination, non-restorative stress.

Why Semax might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.
  3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.
  4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.

Why Selank might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Anxiety — Arousal without calm → jitter, rumination, non-restorative stress.
  3. What Selank is studied to do: Studied for anxiolytic pathways without classic benzodiazepine sedation.
  4. Therefore for you: If that layer is part of your problem, Selank is discussed because it targets repair (anxiety / neurochemistry) — not because it masks pain.

Why DSIP might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Layer breaking down: Sleep — Stimulants delay sleep onset and cut deep sleep.
  3. What DSIP is studied to do: Studied for sleep architecture and deep-sleep promotion.
  4. Therefore for you: If that layer is part of your problem, DSIP is discussed because it targets repair (sleep / repair window) — not because it masks pain.

Why NAD+ might help you

  1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.
  2. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.

Why Amphetamine stimulants matters for you

  1. Drug: Amphetamine stimulants
  2. What it does: Forces neurotransmitter release; borrows focus at cost of sleep/gut reserve.
  3. Therefore for you: state whether this drug reduces load, suppresses a signal, or supports metabolism — and whether that helps or trades off repair for your condition.

How these fit together

Neural support (Semax), non-benzo calm (Selank), sleep repair window (DSIP) — each targets a stimulant-degeneration layer.

  • Semax → neural / cognitive
  • Selank → anxiety / neurochemistry
  • DSIP → sleep / repair window
  • NAD+ → cellular energy

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 6
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 3
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 0
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 7

Logic: No social posts catalogued yet — we cannot report what people are saying on Reddit or X from this ledger.

Quantified confidence (this ledger): 0.41 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Semax, an analogue of adrenocorticotropin (4-10), is a potential agent for the treatment of attention-deficit hyperactivity disorder and Rett syndrome (source s0)

Reviews Semax effects including BDNF in animals.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Semax, an analogue of adrenocorticotropin (4–10), is a potential agent for the treatment of attention-deficit hyperactivity disorder (source s1)

Proposes Semax for ADHD based on dopamine and BDNF data.

Evidence type: Published research.

Semax, an analogue of adrenocorticotropin (4-10), binds specifically to the rat basal forebrain (source s6)

Direct rat BDNF measurement after Semax.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Efficacy and possible mechanisms of action of a new peptide anxiolytic Selank (source s12)

Human GAD trial results.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

DSIP reduces amphetamine-induced hyperthermia in mice (source s15)

Animal thermoregulation data with amphetamine.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

NAD Therapy for Addiction: What to Know (source s21)

Summarizes historical NAD observations in substance issues.

Evidence type: Published research.

Peptide components (collapsible embeds)

Semax: BDNF Upregulation · neural / cognitive · semax
{
  "peptide": "semax",
  "regenerative_layer": "neural / cognitive",
  "targets_this_degeneration": "BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.",
  "proposed_regeneration": "Studied for BDNF and neural support — building connections, not sedating symptoms.",
  "evidence_in_ledger": {
    "human_claims": 8,
    "preclinical_claims": 6,
    "anecdote_claims": 68,
    "studies_catalogued": 32
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/semax"
}

Overview Semax is described as a brain peptide that upregulates BDNF. Preclinical Evidence (Rat Studies) In rat hippocampus, a single intranasal dose of Semax (50 μg/kg) produced a maximal 1.4-fold increase in BDNF protein levels, accompanied by increased trkB phosphorylation and mRNA expression (preclinical tier). [Do…

Full semax article →
Selank: Non-Sedating Anxiolytic · anxiety / neurochemistry · selank
{
  "peptide": "selank",
  "regenerative_layer": "anxiety / neurochemistry",
  "targets_this_degeneration": "Chronic stress chemistry, stimulant jitter, non-restorative arousal.",
  "proposed_regeneration": "Studied for anxiolytic pathways without classic benzodiazepine sedation.",
  "evidence_in_ledger": {
    "human_claims": 13,
    "preclinical_claims": 8,
    "anecdote_claims": 60,
    "studies_catalogued": 31
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/selank"
}

Overview Selank is a synthetic heptapeptide derived from tuftsin with reported anxiolytic properties. Human Data A 2008 randomized study compared intranasal Selank to medazepam in 62 patients with generalized anxiety disorder and neurasthenia. Preclinical Data Rat studies show alterations in gene expression related to …

Full selank article →
DSIP: Natural Deep Sleep · sleep / repair window · dsip
{
  "peptide": "dsip",
  "regenerative_layer": "sleep / repair window",
  "targets_this_degeneration": "Lost deep sleep — when growth hormone and tissue repair cycles run.",
  "proposed_regeneration": "Studied for sleep architecture and deep-sleep promotion.",
  "evidence_in_ledger": {
    "human_claims": 9,
    "preclinical_claims": 4,
    "anecdote_claims": 72,
    "studies_catalogued": 26
  },
  "confidence_0_to_1": 0.95,
  "confidence_label": "moderate (human data present)",
  "full_article": "https://miscsubjects.com/a/dsip"
}

Evidence-Graded Overview DSIP (Delta Sleep-Inducing Peptide) is a nonapeptide first isolated from rabbit cerebral venous blood. Preclinical studies in multiple species have examined its association with slow-wave sleep. Preclinical Data (Animal and Cell Studies) Rat studies link endogenous DSIP to slow-wave sleep (SWS)…

Full dsip article →

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

stimulants · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
Evidence · 7 sources · swipe →chain 720177cd5370 · verify chain · provenance
Evidence ledger 5 · tier-ranked · API
human
Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients.
sources: s12
preclinical
Semax increases BDNF levels in rat basal forebrain after intranasal application.
sources: s6, s0
preclinical
DSIP reduced amphetamine-induced hyperthermia in mice at certain doses.
sources: s15
preclinical
NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models.
sources: s19
anecdotal
Small human trials link intravenous NAD to substance use disorder recovery observations.
sources: s21
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:41
NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers · 5 claims · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: NAD Plus for Stimulants
Slug: nad-plus-stimulants
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"multi_stack","condition":"Stimulant load (Adderall / amphetamine)","condition_key":"adderall-stimulant","primary_peptide":null,"peptides_in_scope":[{"id":"semax","name":"Semax"},{"id":"selank","name":"Selank"},{"id":"dsip","name":"DSIP"},{"id":"nad-plus","name":"NAD+"}],"drugs_in_scope"
it output
{
  "slug": "nad-plus-stimulants",
  "title": "NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers",
  "body": "## What's breaking down if you have Stimulant load (Adderall / amphetamine)\n\nAmphetamines force dopamine and norepinephrine release. This borrows focus now.\n\nSleep, appetite, and gut lining often suffer. Less regeneration window follows.\n\nChronic load can deplete neurochemistry and stress the gut-brain axis.\n\nFour layers show the mismatch between breakdown and repair:\n\n- Dopamine system: Forced release leads to depletion, crash, anhedonia, and tolerance.\n- Sleep: Stimulants delay onset and cut deep sleep stages.\n- Gut: Mucosa faces stress; inflammation feeds back to mood and cognition.\n- Anxiety: Arousal without calm produces jitter, rumination, and non-restorative stress.\n\n## Why Semax might help you\n\n1. You have Stimulant load (Adderall / amphetamine) — breakdown is outpacing repair.\n2. What keeps failing: BDNF decline, stimulant-induced neuro stress, cognitive fatigue after dopamine load.\n3. What Semax is studied to do: Studied for BDNF and neural support — building connections, not sedating symptoms.\n4. Therefore for you: If that layer is part of your problem, Semax is discussed because it targets repair (neural / cognitive) — not because it masks pain.\n\n## Why Selank might help you\n\n1. You have Stimulant load (Adderall 
d74bbb8db3bc0837
Machine verification: /api/articles/nad-plus-stimulants/contributions
Ask this article · 7 suggested prompts

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Selank showed anxiolytic effects comparable to medazepam in a trial of 62 GAD patients."?
ask nad-plus-stimulants claim c2 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Semax increases BDNF levels in rat basal forebrain after intranasal application."?
ask nad-plus-stimulants claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "DSIP reduced amphetamine-induced hyperthermia in mice at certain doses."?
ask nad-plus-stimulants claim c3 · paste includes §SELF
What does the ledger say about this (preclinical tier): "NAD+ metabolism is implicated in addictive behavior and cravings in preclinical models."?
ask nad-plus-stimulants claim c4 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Small human trials link intravenous NAD to substance use disorder recovery observations."?
ask nad-plus-stimulants claim c5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers — and what would you need me to tell you first?
ask nad-plus-stimulants condition gaps · paste includes §SELF
What good and bad outcomes are documented for NAD+ and Related Peptides for Stimulant Load: Evidence on Repair Layers (studies vs anecdotes)?
ask nad-plus-stimulants good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…